Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

New bipartisan legislation would increase awareness about what’s in food. Products that contain certain dyes and chemicals would be required to have warning ...

scPharmaceuticals reported a net loss of $18.8 million for the fourth quarter of 2024, compared to $13.8 million for the fourth quarter of 2023. For the full-year 2024, scPharmaceuticals reported a ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...

Targeting final FDA approval of YUTREPIA after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil products in clinical studiesStrengthened financial positio ...

With companies constantly developing new therapies and technologies, the biotech industry is a hotbed of innovation. This dynamic environment ...

FDA granted priority review to Company's BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis and set PDUFA target action date ...

The Company will provide further updates following communications with the FDA when additional information is available.

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Nestle USA has recalled certain batches of its Lean Cuisine and Stouffer's frozen meals. The products could be contaminated ...

Nestlé USA cites consumer complaints, including "one potential choking incident" for recalling products sold nationwide.